12
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Mobilizatiod/Transplantation of Peripheral Blood Progenitor Cells for Aggressive Non-Hodgkin's Lymphoma with Marrow Involvement

, , , , , , , , , , , , , , , , & show all
Pages 83-88 | Published online: 01 Jul 2009

References

  • Cahanillas F., Hagemeister F. B., McLaughlin P., Velasquez W. S., Riggs S., Fuller L., Smith T. Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 1987; 5: 407–410
  • Velasquez W. S., Cahanillas F., Salvador P., McLaughlin P., Fridrik M., Tucker S., Jagannath S., Hagemeister F. B., Kedman J. R., Swan F., Barlogie B. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone. Blood 1988; 71: 117–122
  • Velasquez W. S., McLaughlin P., Tucker S., Hagemeister F. B., Swan F., Rodriguez M. A., Romeguera J., Rubenstein E., Cabanillas F. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-yeer follow-up study. J. Clin Oncol 1994; 12: 1169–1176
  • Armitage J. Bone marrow transplantation in the treatment of patients with lymphoma. Blood 1989; 73: 1749–1758
  • Grihhen J. G., Goldstone A. H., Linch D. C., Taghipour C., McMillan A. K., Souhami R. L., Earl H., Richards J. D. M. Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy. J Clin Oncol 1989; 7: 1621–1629
  • Philip T., Guglielmi C., Hagenheek A., Somers R., Lelie H. V. D., Bron D., Sonneveld P., Gisselbrecht C., Cahn J. Y., Harousseau J. L., Coiffier B., Biron P., Mandelli F., Chauvin F. Autologous bone marrow transplantation as compared with salvage chcmotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540–1545
  • Hardingham J. E., Kotasek D., Sage R. E., Dobrovic A., Gooley T., Dale B. M. Molecular detection of residual lyniphoina cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 1993; 11: 15–20
  • Tarella C., Ferrero D., Bregni M., Siena S., Gallo E., Pileri A., Gianni A. Peripheral blood expansion of early progeniror cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 1991; 27: 22–27
  • Dreyfus F., Lehlond V., Belanger C., Gabarre J., Sutton L., Boccnccio C., Quarre M. C., Ribrag V., Goy A. Peripheral blood stein cell collection and autografting in high risk lymphomas. Bone Marrow Transplant 1992; 10: 409–413
  • Klumpp T. R., Mangan K. F., Glenn L. D., Malaspina D. R., Cropper T., Mullaney M., Macdonald J. S. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed hy autologous hone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. Bone Marrow Transplant 1993; 12: 337–345
  • Siena S., Bregni M., Brando B., Belli N., Ravagnani F., Candola L., Stern A. C., Lansdorp P. M., Bonadonna G., Gianni M. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400–409
  • Kaplan E. L., Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457–481
  • Kotasek D., Shepherd K. M., Sage R. E., Dale B. M., Norman J. E., Charles P., Gregg A., Pillow A., Holton A. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992; 9: 11–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.